Lantheus Holdings, Inc. Restructuring and Related Cost, Number of Positions Eliminated
Lantheus Holdings, Inc. (LNTH) reported Restructuring and Related Cost, Number of Positions Eliminated of 75 Employee for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2026-02-26
- Lantheus Holdings, Inc. restructuring and related cost, number of positions eliminated for the quarter ending 2024-12-31 was 60.00 employee.
employee
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 3 month |
|---|---|
| 2024-12-31 | 60.00 employee 10-K · filed 2025-02-26 |
Employee
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 12 month |
|---|---|
| 2025-12-31 | 75.00 Employee 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |